>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:

  • AAP -25.5%, AMBA -18.3%, HPE -8.4%, SPWH -7.8%, FRO -6%, HPQ -5.9%, UHAL -3.2%, CPRI -1.5%

Other news:

  • BLTE -37.2% (prices offering of ADSs and warrants)
  • ASLE -10.1% (prices secondary offering of 4.0 mln shares of common stock by selling shareholders)
  • PEPG -9.7% (clinical hold on IND application of PGN-EDODM1)
  • HRZN -8.8% (prices offering of 3.25 mln shares of common stock at $12.50 per share)
  • LTRX -8.6% (CEO to step down)
  • PUK -4.3% (CFO resigns; appoints Ben Bulmer as CFO)
  • EGO -3.8% (announces C$81.5 mln strategic investment by EBRD and concurrent C$135 mln bought deal financing)
  • COIN -2.9% (SEC settles with former product manager and his brother on insider trading charges)
  • MERC -1.7% (receives court approval to acquire Structurlam Mass Timber assets)
  • KODK -1.6% (acquires Graphic Systems Services)
  • BMBL -1.2% (president to resign)
  • FRPT -1% (responds to JANA Partners' letter)

Analyst comments:

  • PDCE -1.7% (downgraded to Neutral from Buy at Seaport Research Partners)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:

  • BOX +0.5%

Other news:

  • LL +20.5% (F9 Investments prepared to consider an offer of $5.76/sh for LL)
  • CCO +3.9% (closes sale of Italy business to JCDecaux SE (JCDXF) for approx. $16.2 mln (EUR15.1 mln))
  • TWLO +3.7% (will lose supervoting protection next month; also co has been meeting with activist according to TheInformation)
  • CAE +3% (awarded $455 mln subcontract for US Army Flight School)
  • ANIK +2.1% (completes enrollment in Hyalofast phase 3 study)
  • NAAS +2.1% (announces $21 million of registered direct offering to certain investors)
  • IGMS +1.9% (announces FDA clearance to begin clinical studies of imvotamab in lupus and rheumatoid arthritis)
  • SMTC +1.2% (names new CEO)
  • SNY +1.1% (reports Phase 2 data of novel investigational anti-CD40L antibody frexalimab show significantly reduced disease activity in relapsing multiple sclerosis)

Analyst comments:

  • CAR +4.1% (upgraded to Buy from Hold at Deutsche Bank)
  • QTWO +2.9% (upgraded to Buy from Neutral at BTIG Research)

(Makor) STARB SS rights issue - one pager


All,

 

New rights issue in Sweden. Very small for SEK 450m or €38m.

Note that the company is issuing A and B shares so 2 spreads but the one-pager below is using the most liquid B shares.

Ticker of the A shares is STARA SS and right is STARTRA SS.

Was ex on May 29th and start trading tomorrow.

 

>>> US Early premarket gappers

Early premarket gappers

  • Gapping up:
    • LL +21.7%, CCO +5.5%, CPRI +4.4%, TWLO +3.5%, CAE +3.1%, BOX +2.5%, ANIK +2.1%, NAAS +2.1%, MRTX +1.1%, SNY +1.1%, RC +0.9%, GLDD +0.6%, MCRB +0.6%, UCBI +0.6%
  • Gapping down:
    • BLTE -37.1%, AAP -24.9%, AMBA -17.7%, PEPG -16.3%, ASLE -9.7%, HRZN -8.1%, HPE -7.9%, SPWH -7.8%, LTRX -7.6%, FRO -5.7%, EGO -5.2%, HPQ -4.8%, PUK -4%, UHAL -3.2%, COIN -2.2%, MERC -1.7%, FRPT -1%, KODK -0.8%, BMBL -0.8%

>>> Europe : Brokers Upgrades & Downgrades - 31st of May 2023 V2(+)

>>> Up
* Austriacard Raised to Buy at Raiffeisen Bank; PT 14.50 euros
* BW Epic Kosan Ltd Raised to Buy at Norne Securities (+)
* Chevron Raised to Neutral at JPMorgan; PT $170
* J D Wetherspoon Raised to Buy at HSBC; PT 940 pence
* Mediobanca Raised to Add at AlphaValue/Baader
* Mitchells & Butlers Raised to Buy at HSBC; PT 300 pence

>>> Down
* 3i Cut to Add at Numis; PT 2,285 pence
* Ambarella Cut to Sector Weight at KeyBanc
* Datalex Cut to Neutral at Davy (+)
* DWF Group Cut to Sell at Liberum; PT 50 pence
* Enefit Green Cut to Neutral at Citi; PT 4.90 euros
* Inmobiliaria Colonial Cut to Reduce at AlphaValue/Baader
* Nokian Renkaat Cut to Add at AlphaValue/Baader
* Norrhydro Group Cut to Reduce at Inderes; PT 3.20 euros

>>> Initiation
* Bilia Rated New Buy at DNB Markets; PT 130 kronor
* BNP Paribas Reinstated Neutral at Goldman; PT 76 euros
* Dowlais Rated New Underperform at BNPP Exane; PT 120 pence
* Inventiva SACA ADRs Rated New Buy at Roth MKM; PT $11
* MorphoSys Rated New Buy at UBS; PT 47 euros
* Nice Ltd ADRs Rated New Buy at Mizuho Securities; PT $244
* Ocado Rated New Neutral at Davy; PT 400 pence (+)
* Recordati Rated New Sector Perform at RBC; PT 43.50 euros
* Solid State Rated New Buy at Cenkos Securities (+)
* Vossloh Rated New Buy at Quirin Privatbank AG; PT 51.37 euros (+)

>>> Call
* BT, Hellenic Telecom Are Top Picks at Citi Into Second Quarter
* Chevron Loses Only Sell as JPMorgan Says Premium Has Narrowed
* Femsa Sale of Heineken Shares Removes Overhang Risk: Jefferies (+)
* Recordati Sector Perform at RBC, Premium Reflects Growth Outlook
* Wartsila Gets Upside Catalyst Watch at Citi on Services Business

>>> Stoxx 600 Pre-Market Indications

  • UCB (UNC TH) +0.3%
  • Sanofi (SNW TH) +0.2%
    • Sanofi’s MS Drug Frexalimab Meets Main Goal in Phase 2 Trial
  • Glencore (8GC TH) -1.4%
  • Aixtron (AIXA TH) -1.5%
  • Carl Zeiss Meditec (AFX TH) -1.5%
  • Bechtle (BC8 TH) -1.7%
  • Infineon (IFX TH) -1.9%
  • Air France-KLM (AFR TH) -1.9%
  • BP (BPE5 TH) -2.9%
  • Thyssenkrupp (TKA TH) -3%
  • Prosus (1TY TH) -3.2%
  • Heineken (HNK1 TH) -3.7%
    • Heineken Share Offering by Femsa Prices at €92.75/Share